CME Sponsor:
Scientific Congress Update

Location:
This is a Webcast CME activity

Course Directors/Instructors:
Craig Leonardi, MD (program chair)
Clinical Professor of Dermatology
Saint Louis University
St. Louis, MO

Bruce Strober, MD, Ph.D.
Assistant Professor, Department of Dermatology
NYU Medical Center
New York, NY

Richard Langley, MD
Professor of Dermatology and Director of Research
Division of Dermatology
Dalhousie University
Halifax, Nova Scotia, Canada

Andrew Blauvelt, MD
Joel Gelfand, MD
Kenneth Gordan, MD
Alan Menter, MD
Ronald Prussick, MD, PC
Stephen K. Tyring, MD.
Abby S. Van Voorhees, MD
Henry K. Wong, MD

Number of Credits: 1.0 AMA PRA Category 1 Credit(s)™

Registration Fee: Free

More Info

Detailed Description: 

Latest Developments if the Use of Biologics in the Treatment of Psoriasis: from Research to Practice is the second of 3 certified, sixty-minute programs covering current and new treatment modalities for Psoriasis along with the impact on daily practice of new data released at key dermatology meetings and conferences in 2009.

The program includes a studio-based panel of experts from leading medical centers, breaking news from our medical reporter Erin Carey and prerecorded interviews with investigators attending the American Academy of Dermatology (AAD) Scientific Sessions 2009 in San Francisco.

The program focuses on 4 main areas:

  • T-Cell inhibitors and anti TNF-alpha agents
  • Efalizumab discontinuation: practical strategies
  • New psoriasis data from AAD Sessions 2009
  • Challenging psoriasis cases

Learning Objectives:
  • Describe findings from key clinical trials in the area of biologics for the treatment of psoriasis and psoriatic arthritis
  • Describe the pharmacologic action of new biologic agents
  • Discuss the proposed place in therapy of new biologic agents
  • Implement new treatment strategies in their clinical practice, to optimize patient care, using existing treatment modalities
  • Describe the long term safety profile of the existing biologic agents and the advantages and disadvantages associated with their use
  • Describe future treatment strategies designed to improve patient quality of life and acceptability of biologic agents 
Intended Audience:

This program was developed to provide primary care physicians and other healthcare professionals who care for and treat patients with psoriasis with the most up-to-date information being disseminated on therapeutic options for the management of psoriasis.